Business Wire

Seoul Semiconductor Sues Big-Box TV Retailer for Infringement of 15 LED Patents in U.S. Court

Del

Seoul Semiconductor (KOSDAQ:046890), a leading global innovator of LED products and technology, announced that it has filed a patent infringement lawsuit in the United States District Court for the Eastern District of Texas, together with its affiliate, Seoul Viosys Co., Ltd. (collectively “Seoul”), against Fry’s Electronics (“Fry’s”), a retail company of consumer electronics. The patent litigation concerns Fry’s sales of various LED television products.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180904005182/en/

Seoul Semiconductor's Key Patented Technologies for TV Backlight (Graphic: Business Wire)

Seoul Semiconductor's Key Patented Technologies for TV Backlight (Graphic: Business Wire)

Fry’s is one of the largest big-box retailer of consumer electronics in the United States. It has 17 mega-stores in California and 14,000 employees. Fry’s currently offers more than 300 LED television models featuring twenty-five different global TV brands.

In its complaint, Seoul asserts that certain LED TV products in Fry’s stores infringe 15 of Seoul’s LED patents that relate to manufacturing processes for LED backlight units. Seoul’s patented technologies cover LED TV backlight unit structures, LED backlight lenses for providing uniform illumination of LED lights, UCD technology for high color gamut displays, LED packaging, LED chip fabrication, and LED epitaxy. These are significant technologies to improve the color, brightness, and duration time of all LCD light sources such as smartphones, laptops, tablet PCs and monitors as well as TVs.

In particular, optical lens technology for offering uniform light distribution on TV or monitor displays is one of the most significant LED backlight technologies that Seoul has developed since the earliest days of LCD backlights.

In order to protect that patented technology, Seoul actively enforces its patent rights against suspected-infringers. For example, in 2016, Seoul prevailed in U.S. federal court against Japanese lens maker, Enplas, with a judgment finding that Enplas willfully infringed one of Seoul’s LED backlight lens patents, as well as one of Seoul’s LED backlight system patents. Over the past few years, Seoul has also pursued patent litigation for infringement of LED backlight lens and other components patents against North America TV maker Craig Electronics and Curtis International and successfully obtained patent royalties from both companies.

UCD technology (KSF) is another of Seoul's core LED backlight technologies that enables significant improvement of color gamut of LCD displays such as TVs and smartphones, which has been co-developed with a Japanese corporation for a long time. By enabling green and red light generated with KSF phosphors, UCD technology delivers 92-93% NTSC, which is higher than that of OLED.

Prior to the filing of its most recent litigation, Seoul delivered notices of patent infringement to various global TV brand makers, as well as their suppliers who manufacture TV modules or TV sets in various regions of Asia, including China and Taiwan, through OEM or ODM. Seoul advised these TV makers and manufacturers that they needed to stop using LEDs and/or other components that likely infringe Seoul’s LED backlight lens and UCD technology patents.

“For young entrepreneur and small business entities to develop innovative products under fair competition culture, it is necessary for market participants to respect other companies’ intellectual property rights,” said Sam Ryu, Seoul’s Vice President of IT Business. “To prevent distribution of suspected-infringing products, we are thoroughly investigating various global TV brand products that may infringe our patents. If these companies continue to use products that are suspected of infringement, despite our requests to stop, we will take all the necessary legal actions to the end.”

About Seoul Semiconductor

Seoul Semiconductor develops and commercializes LEDs for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC.

Contact information

Seoul Semiconductor Inc.
Jeonghee Kim, +82-70-4391-8311
jeonghee.kim@seoulsemicon.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Janssen Seeks Expanded Use of IMBRUVICA®▼ (ibrutinib) in Two Indications in Europe14.11.2018 14:23Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two Type II variation applications to the European Medicines Agency (EMA) seeking approval for the expanded use of IMBRUVICA® (ibrutinib). One application seeks to include use of ibrutinib in combination with obinutuzumab in previously untreated adults with chronic lymphocytic leukaemia (CLL) and to add long-term follow-up data from the existing label studies RESONATETM (PCYC-1112) and RESONATETM-2 (PCYC-1115). The second is for use of ibrutinib plus rituximab for the treatment of previously untreated and relapsed/refractory adults with Waldenström's macroglobulinemia (WM). “Today’s news brings us one step closer to potentially offering ibrutinib in new combinations for patients where unmet needs still persist,” said Dr. Catherine Taylor, Haematology Therapy Area Lead, Europe, Middle East and Africa (EMEA), Janssen-Cilag Limited. “Ibrutinib continues to demonstrate clinical benefit over the long

ResMed Completes Acquisition of MatrixCare14.11.2018 14:05Pressemelding

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its $750 million acquisition of Minnesota-based MatrixCare, a leader in software solutions for more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005282/en/ These care settings are complementary to ResMed’s other SaaS offerings in home medical equipment, home health and hospice, delivered through Brightree and HEALTHCAREfirst, acquired by ResMed in April 2016 and July 2018, respectively. ResMed will drive an integrated ecosystem of solutions across these platforms to maintain single-patient records across multiple care settings, generate analytics and insights that can be applied to individuals and whole populations, and streamline processes acr

REPLY: The Board of Directors Approves the Quarterly Financial Report as of 30 September 201814.11.2018 13:30Pressemelding

Today, the Board of Directors of Reply [MTA, STAR: REY] approved the results as at 30 September 2018. In the first nine months of the year, the Group has recorded a consolidated turnover of €754.4 million, with an increase of 15.8% compared to €651.3 million at September 2017. Consolidated EBITDA to September was €101.2 million (€89.8 million at September 2017) with an EBIT of €91.4 million (€81.7 million at September 2017). Pre-tax profit amounted to €96.3 million, which represents an increase of 22.4% compared to the same period of 2017. For the third quarter of 2018 (July-September), the Group registered a consolidated turnover of €256.3 million (€209.7 million in 2017), an EBITDA of €32.9 million (€28.0 million in 2017), an EBIT of €29.3 million (€24.7 million in 2017) and a pre-tax profit of €32.1 million (25.3 million in 2017). As at 30 September 2018, the Group's net financial position was positive for €56.3 million, improving compared to €50.2 million registered on June 30, 201

Blackjack Booster Lands at Intertops Poker14.11.2018 13:20Pressemelding

Intertops Poker is boosting player winnings this weekend with an extra 10% on the Lucktap games Blackjack, Face Up 21, Double Draw Blackjack and Perfect Pairs Blackjack. The promotion is being offered exclusively through the Intertops Poker software, and will run from Friday 16th November to Sunday 18th November. To access the promotion, players log into the Intertops Poker software and click the Casino tab in the top right hand corner. They then chose from one of the Lucktap games (Blackjack, Face Up 21, Double Draw Blackjack and Perfect Pairs Blackjack) offered and any winning bets will be increased by 10%. The additional 10% winnings will be shown as a bonus balance and will be released once the x15 wagering requirement has been met. The maximum prize that can be won is $250. The poker manager at Intertops Poker, said: “Here at Intertops Poker we are always looking to provide our players with even more value, which is why we are boosting all winnings on our Lucktap games by 10% this

Corsearch Announces Acquisition of Yellow Brand Protection14.11.2018 13:00Pressemelding

Corsearch Inc. and its related entities, a trademark and domain solutions leader, is pleased to announce the acquisition of Yellow Brand Protection AB of Sweden, a leading global provider of online anti-counterfeiting and brand protection services. The acquisition, effective immediately, solidifies and further expands Corsearch’s full service brand protection offering for clients and brands globally . The facts speak for themselves in this industry – In 2018, online sales will approach $3 trillion U.S. Dollars, with one in four online purchases involving pirated goods. Online IP infringement is a continued and increasingly expanding challenge for all brands, as e-commerce growth continues at record speed and digital marketing becomes a core business strategy. Corsearch, founded in 1949, provides industry-leading brand establishment and protection services for trademark and brand professionals in over 60 countries on five continents. Yellow Brand Protection, founded in 2010, provides br

PEI-Genesis Approved as Category C Distributor for All Conesys Product Lines14.11.2018 11:15Pressemelding

PEI-Genesis, the world’s fastest assembler of precision connectors, has been approved as a Category C Distributor for all Conesys product lines. PEI-Genesis will be assembling all government approved Mil-Circular connector product lines manufactured by Conesys at the company’s South Bend, IN facility. “The addition of Conesys Mil-Circular connectors gives global, value-added access to all customers and adds to the breadth of Conesys’ offerings,” said Peter Austin, PEI-Genesis’s Senior Vice President of Manufacturing, Product Management, Marketing, & Training. “The new partnership will give Conesys access to our award-winning service and largest available-to-sell connector inventory.” PEI-Genesis has inventory to assemble Conesys connectors now, and will be able to assemble over 50,000 military connector part numbers from Conesys inventory very soon. Product families being assembled by PEI-Genesis for Conesys include the MIL-DTL-38999, MIL-DTL-26482, MIL-DTL-83723, and MIL-DTL-26500. “W